Navigation Links
bioMETRX, Inc. Calls Series B Warrants
Date:9/3/2007

Institutional Investors Convert Debentures to Equity

JERICHO, N.Y., Aug. 15 /PRNewswire-FirstCall/ -- bioMETRX, Inc. (OTC Bulletin Board: BMRX), a leading developer and supplier of consumer biometric products, today announced that it is has provided notice to certain holders of its Series B common stock warrants that such holders must surrender said warrants to the company by August 25, 2007.

The Company notified holders of 375,000 series B $0.10 warrants that it has elected to pay such holders $0.12 per share, pursuant to the warrant documents by providing contractual 10 days written notice of said action. The Company has fixed the call date of such warrants as of August 15, 2007. The warrant holders so notified must return the series B warrants by August 25, 2007 to receive payment. The holders so notified do not have the right to exercise the series B warrants after the call date.

The company also announced that in connection with previous financings totaling $3,100,000, that $1,175,000 of that debt has been converted to equity by such holders.

About bioMETRX, Inc.

bioMETRX, Inc. designs, develops and markets biometrics-based products to the consumer, market under the common brand name - smartTOUCH(TM); bioMETRX Technologies, Inc. designs and engineers biometrics-based products for the home security and consumer electronics markets; smartTOUCH Consumer Products, Inc. tests and markets the company's biometrically secured products

For more information on bioMETRX and/or the company's smartTOUCH line of products including the Garage Door Opener, visit the Company website at http://www.biometrx.net

Safe Harbor Statement: This release may contain certain forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Forward-looking statements in this release with respect to bioMETRX's business, financial condition o
'/>"/>

SOURCE bioMETRX, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology news :

1. NIH Calls on Scientists to Speed Public Release of Research Publications
2. Report calls for improved monoclonal antibodies against solid tumors
3. Johns Hopkins flu expert calls for mandatory vaccination of health care workers
4. Empty nester parent birds use recruitment calls to extend offspring care
5. Male reindeer inflate a large air sac in the neck region to emit their hoarse rutting calls
6. FDA Announces Series of Changes to the Class of Marketed Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
7. Mercury contamination of fish warrants worldwide public warning

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...alifornia biomedical engineer and cardiologist Tzu...p clinicians distinguish cardiac emergencies requi...eable with drugs and lifestyle change. , Angiogr...teries feeding the heart, offer an inside view of ...els, often revealing deposits of a dangerous fatty...
(Date:11/23/2009)...General Medical Sciences (NIGMS), part of the Nati...3 million for grants in scientific areas it identi...the GO grant program to stimulate biomedical resea...erican Recovery and Reinvestment Act (Recovery Act...o have a significant impact on a field of biomedic...
(Date:11/23/2009)... is Director of the Interuniversity Professorship ...and the University of the Basque Country. The Prof...as other experts such as researchers in the fields...ts in ethics. , The Interuniversity Professorshi... of Deusto and the Basque Country was created in 1...
Breaking Biology News(10 mins):Stable plaque or heart attack plaque? USC researcher builds new sensor to tell which is which 2NIGMS invests in scientific Grand Opportunities with Recovery Act funds 2NIGMS invests in scientific Grand Opportunities with Recovery Act funds 3Research and legislation should go hand in hand, as much as possible 2A tiny frozen microbe may hold clues to extraterrestrial life 8822 1A tiny frozen microbe may hold clues to extraterrestrial life 8822 2Advance in understanding cellulose synthesis 8820 1Advance in understanding cellulose synthesis 8820 2Advance in understanding cellulose synthesis 8820 3Keep Safety in Mind While Cooling Off in the Water 48824 1Keep Safety in Mind While Cooling Off in the Water 48824 2
... Four hundred researchers tapping the massive flow...30 to share their recent developments at the 2nd A...tute (DOE JGI) User Meeting. DOE JGI is the world,...ughput DNA sequencing available to a diverse resea...erwise would not have access to such a resource to...
... A team of Canadian researchers, lead by Dr. Susan...iction and Mental health (CAMH), discovered a dist...mposed of two different types of dopamine receptor...n understanding and treating schizophrenia. , Publ...f Sciences USA (Rashid et al., 2007), this importa...
... Some day, heart attack survivors might have a pat...t, to replace areas that died during their attack....et new ones that can grow in place, rather than be...ged or weak blood vessels might get a new “natural...se possibilities are all within reach, and could t...
Other Biology News:New dopamine brain target discovered 2Engineering the heart piece by piece 2Engineering the heart piece by piece 3Engineering the heart piece by piece 4
(Date:11/24/2009)..., ST.LOUIS,Nov.24/PRNewswire-FirstCall/--Sigma-Ald...eNASDAQOMXconferenceonTuesday,December1stat1:45PMG...vialiveaudiobroadcastovertheInternetavailableat h...rscanclickthe"Webcast"icontoaccessthisfile. ,, ...ScienceandHighTechnologycompany.Itschemicalandbioc...
(Date:11/24/2009)..., SANMATEO,Calif.,Nov.24/PRNewswire-FirstCall/--Ne...anyfocusedondevelopingandcommercializingnovelpainm...o,PresidentandChiefExecutiveOfficer,isscheduledtop...nce,tobeheldDecember1-2,2009atTheNewYorkPalaceHote...lieri,ChiefFinancialOfficer,willbeavailabletorespo...
(Date:11/24/2009)... ,Primaryefficacyendpointhasbeenmetforpatientswith..., QUEBECCITY,Nov.24/PRNewswire-FirstCall/-AEternaZ...globalbiopharmaceuticalcompanyfocusedonendocrineth...afromaPhase2studywithitstargetedcytotoxicpeptideco...ancedorrecurrentendometrialcancer.Inapersonalizedh...
(Date:11/24/2009)..., REDWOODCITY,Calif.,Nov.24/PRNewswire-FirstCall/-...atRandyScott,GenomicHealth,sExecutiveChairman,will...enceinNewYorkCityonTuesday,December1,2009at10:00a....webcastofthepresentation,visittheInvestorRelations...genomichealth.com .Pleaseconnecttothewebsiteatleas...
Breaking Biology Technology:NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Genomic Health to Present at Piper Jaffray Health Care Conference 2
...apeutics,Inc. (MTI), a company that discovers and ...gs, announces that it has retained Marquant Partne...se on its strategic and partnering,opportunities, ...lders., This appointment follows a significant am...financial and pharmaceutical companies after its,a...
...a-,Aldrich Corporation announced today that it wil...dnesday, March 19, 2008 at its Life Science & High...uis, Mo. 63103, The event will begin at 8:30 a.m....be webcast over the Sigma-Aldrich website at, http...Sigma-Aldrich is a leading Life Science and High,T...
...Deliver Electronic X-ray-Based, Therapy Directly ...tings, SUNNYVALE, Calif., March 17 Xoft, Inc., t...ance from the U.S. Food & Drug,Administration (FDA...m, a,proprietary technology platform designed to d...iation treatment in minimally-shielded,clinical se...
Other Biology Technology:Mercury Therapeutics, Inc: Marquant Appointed to Advise on Strategic and Partnering Opportunities 2Mercury Therapeutics, Inc: Marquant Appointed to Advise on Strategic and Partnering Opportunities 3FDA Clears Expanded Use of Xoft's Axxent(R) Electronic Brachytherapy System for all Radiation Therapy Indications 2
Mouse Anti-DNA-PKcs, phospho (Thr2609) Monoclonal Antibody, Unconjugated, Clone 10B1 from BioLegend
Rabbit Anti-Histamine H2 Receptor Polyclonal Antibody, Unconjugated from IMGENEX
NF kappa B Related Sampler Kit from BD Biosciences Pharmingen
Glycogen Coprecipitant from Bioline
Biology Products: